ArticleBone marrow transplantation2017

Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era.

L Hegerova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.